DBRC
CVS icon

D.B. Root & Company’s CVS Health CVS Stock Holding History

D.B. Root & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,910
Closed -$349K – 186
2024
Q2 		$349K Sell
5,910
-9,231
-61% -$577K 0.12% 143
2024
Q1 		$1.21M Sell
15,141
-1,856
-11% -$142K 0.41% 60
2023
Q4 		$1.34M Buy
16,997
+614
+4% +$43.7K 0.49% 51
2023
Q3 		$1.14M Sell
16,383
-20
-0.1% -$1.42K 0.45% 61
2023
Q2 		$1.13M Buy
16,403
+1,268
+8% +$90.2K 0.43% 64
2023
Q1 		$1.12M Buy
15,135
+1,607
+12% +$135K 0.44% 66
2022
Q4 		$1.26M Buy
13,528
+552
+4% +$53.3K 0.53% 46
2022
Q3 		$1.24M Sell
12,976
-208
-2% -$20.6K 0.56% 41
2022
Q2 		$1.22M Buy
13,184
+203
+2% +$19.8K 0.52% 47
2022
Q1 		$1.31M Buy
12,981
+52
+0.4% +$5.46K 0.49% 50
2021
Q4 		$1.33M Sell
12,929
-224
-2% -$20.7K 0.48% 47
2021
Q3 		$1.12M Sell
13,153
-64
-0.5% -$5.36K 0.44% 52
2021
Q2 		$1.1M Sell
13,217
-118
-0.9% -$9.66K 0.41% 56
2021
Q1 		$1M Buy
13,335
+3
+0% +$219 0.39% 61
2020
Q4 		$910K Sell
13,332
-1,343
-9% -$87.4K 0.36% 67
2020
Q3 		$857K Sell
14,675
-77
-0.5% -$4.79K 0.34% 76
2020
Q2 		$958K Sell
14,752
-66
-0.4% -$4.16K 0.42% 62
2020
Q1 		$879K Buy
14,818
+954
+7% +$63.7K 0.44% 62
2019
Q4 		$1.03M Sell
13,864
-114
-0.8% -$8.01K 0.45% 62
2019
Q3 		$881K Buy
13,978
+965
+7% +$57.2K 0.41% 71
2019
Q2 		$709K Buy
13,013
+627
+5% +$33.8K 0.31% 93
2019
Q1 		$668K Buy
12,386
+647
+6% +$39.9K 0.29% 100
2018
Q4 		$769K Buy
11,739
+910
+8% +$67.9K 0.38% 83
2018
Q3 		$852K Buy
10,829
+870
+9% +$62.2K 0.38% 85
2018
Q2 		$641K Buy
+9,959
New +$656K 0.3% 114

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

D.B. Root & Company's CVS Position: Q3 2024 in Review

D.B. Root & Company sold out of CVS Health (CVS) in Q3 2024, closing a stake of 5,910 shares — an estimated $349K sold.

D.B. Root & Company first reported a position in CVS in Q2 2018 and held it in 25 quarters. The position peaked at $1.34M in Q4 2023. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • D.B. Root & Company reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • D.B. Root & Company sold 5,910 CVS Health shares in Q3 2024, an estimated $349K.
  • D.B. Root & Company first reported a position in CVS Health in Q2 2018 and held it in 25 quarters.
  • D.B. Root & Company's CVS Health position peaked at $1.34M in Q4 2023.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on D.B. Root & Company's 13F filing for Q3 2024, filed 31 Oct 2024.